Johnson & Johnson, one of the few remaining companies with a top credit rating, is no longer at risk of a downgrade, S&P ...

If you are someone who thinks investments should generate regular income, it is important to watch out for dividend stocks.

Johnson & Johnson has started 2025 better than I expected, even with the long-running talc saga. Find out why I remain ...

President Trump wants to bring manufacturing back to the U.S. These companies say they're investing in domestic factories.

Johnson & Johnson (JNJ) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some ...

Companies with a long history of paying dividends and consistently hiking them remain appealing to income-focused investors.

The company is making a shift to focus on only the highest-value GenAI use cases and shut down pilots that were redundant or ...

Health care giant Johnson & Johnson expects about $400 million in tariff-related costs this year. The costs will be felt ...

Healthcare giant Johnson & Johnson (JNJ)is gearing up to release its first-quarter 2025 financials on April 15. JNJ stock has gained over ...

Shares of Johnson & Johnson (NYSE:JNJ – Get Free Report) were up 0.4% on Wednesday after the company announced better than expected quarterly earnings. The stock traded as high as $155.63 and ...

Johnson & Johnson, while primarily known as America's leading healthcare company, now employs nearly 7,000 digital specialists and data scientists. For example, in the past, researchers trying to ...

Health care giant Johnson & Johnson (JNJ) expects about $400 million in tariff-related costs this year. The costs will be felt primarily within the company's medical technology unit, which makes a ...